Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_assertion type Assertion NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_head.
- NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_assertion description "[Furthermore, knocking down of CXCR4 using RNA interference or inhibition of CXCR4 function by an antagonist AMD3100 not only reduced VEGF production by CD133(+) GSCs in vitro, but also attenuated the growth and angiogenesis of tumour xenografts in vivo formed by CD133(+) GSCs in SCID mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_provenance.
- NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_assertion evidence source_evidence_literature NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_provenance.
- NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_assertion SIO_000772 21618540 NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_provenance.
- NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_assertion wasDerivedFrom befree-20150227 NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_provenance.
- NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_assertion wasGeneratedBy ECO_0000203 NP807937.RA4asL52_v8aCG54MfhSb-ND2FETQ2euj5SQtfubI8nlc130_provenance.